Interview with Jon Soderstrom, Ph.D., managing director of the office of cooperative research at Yale University and moderator of the BIO tech transfer session, and Atul Saran, senior vp of corporate development and ventures at MedImmune

Previous articleOn Supreme Court Docket: Whose Gene Is It Anyway?
Next articleTransplanted Bioengineered Kidneys Successfully Produce Urine